Page last updated: 2024-08-23

silybin and Experimental Neoplasms

silybin has been researched along with Experimental Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, H; Feng, N; He, Y; Hou, X; Liu, Y; Shen, J; Shi, J; Wang, Z; Xie, X1
Chung, SY; Kim, JS; Kim, SH; Lee, CG; Lee, HJ; Lee, M; Rho, JK; Shin, IS; Son, Y; Yang, K1

Other Studies

2 other study(ies) available for silybin and Experimental Neoplasms

ArticleYear
Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis.
    Journal of nanobiotechnology, 2020, May-30, Volume: 18, Issue:1

    Topics: Animals; Antineoplastic Agents; Biological Availability; Breast Neoplasms; Caco-2 Cells; Cell Movement; HT29 Cells; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mucus; Nanoparticles; Neoplasms, Experimental; Phenanthrenes; Rats, Sprague-Dawley; Silybin; Tumor Microenvironment; Xenograft Model Antitumor Assays

2020
The ameliorative effect of silibinin against radiation-induced lung injury: protection of normal tissue without decreasing therapeutic efficacy in lung cancer.
    BMC pulmonary medicine, 2015, Jul-05, Volume: 15

    Topics: Acute Lung Injury; Administration, Oral; Animals; Antioxidants; Dose-Response Relationship, Drug; Female; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Radiation Injuries, Experimental; Silybin; Silybum marianum; Silymarin

2015